Analysts’ Weekly Ratings Changes for Waystar (WAY)

A number of firms have modified their ratings and price targets on shares of Waystar (NASDAQ: WAY) recently:

• 9/3/2026 – Waystar was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 8/31/2026 – Waystar had its price target raised by Canaccord Genuity Group Inc. from $30.00 to $33.00. They now have a “buy” rating on the stock.
• 8/27/2026 – Waystar had its “outperform” rating reaffirmed by BMO Capital Markets.
• 8/27/2026 – Waystar had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $44.00 price target on the stock.
• 8/26/2026 – Waystar had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $33.00 price target on the stock.
• 8/13/2026 – Waystar had its price target lowered by Truist Financial Corporation from $38.00 to $33.00. They now have a “buy” rating on the stock.
• 8/13/2026 – Waystar was upgraded by Wolfe Research to “outperform”.
• 8/7/2026 – Waystar had its price target raised by Barclays PLC from $25.00 to $27.00. They now have an “overweight” rating on the stock.
• 7/31/2026 – Waystar had its “overweight” rating reaffirmed by KeyCorp.
• 7/31/2026 – Waystar had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $39.00 price target on the stock.
• 7/30/2026 – Waystar had its price target lowered by UBS Group AG from $37.00 to $33.00. They now have a “buy” rating on the stock.
• 7/30/2026 – Waystar had its price target lowered by Wells Fargo & Company from $36.00 to $33.00. They now have an “overweight” rating on the stock.
• 7/30/2026 – Waystar had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $33.00 price target on the stock.
• 7/20/2026 – Waystar was given a new $34.00 price target by UBS Group AG.
• 7/20/2026 – Waystar had its “buy” rating reaffirmed by Citigroup Inc..

Insider Transactions at Waystar

In related news, CEO Matthew Hawkins sold 82,500 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $25.97, for a total transaction of $2,142,525.00. Following the completion of the transaction, the chief executive officer directly owned 1,804,794 shares in the company, valued at $46,870,500.18. This trade represents a 4.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 165,000 shares of company stock worth $4,206,524. 3.50% of the stock is currently owned by corporate insiders.

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.